about
Getting the balance right: Established and emerging therapies for major depressive disordersThe use of psychotropic medication during pregnancy: how about the newborn?Moclobemide discontinuation syndrome predominantly presenting with influenza-like symptomsNear infrared spectroscopy study of the frontopolar hemodynamic response and depressive mood in children with major depressive disorder: a pilot studyThe efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patientsWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreWhat is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors.SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and AdolescentsAntidepressant dosage taken by patients with bipolar disorder: factors associated with irregularityReview of sertraline in post-traumatic stress disorder.Medication dependence and anxiety.The pharmacological management of depressionWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.Use of psychopharmacological agents for functional gastrointestinal disorders.Sleep disruption in critically ill patients--pharmacological considerations.Safety and side effect profile of fluoxetine.Venlafaxine extended release (XR) in the treatment of panic disorder.A case report of onset of tinnitus following discontinuation of antidepressant and a review of the literature.The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding.Venlafaxine in the treatment of anxiety disorders.Treatments for generalized anxiety disorder.Current diagnosis and treatment of anxiety disorders.Discontinuation of antidepressant medication among Latinos in the USA.Sertraline inhibits increases in body fat and carbohydrate dysregulation in adult female cynomolgus monkeys.Pharmacological treatment of generalized anxiety disorder.When the bough breaks: rethinking treatment strategies for perinatal depression.New insights on the antidepressant discontinuation syndrome.Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.Recognition and management of antidepressant discontinuation syndrome.A dispensing error resulting in possible fluoxetine overdose and subsequent discontinuation syndrome in a child.Closing the Deal: A Cross-Cultural Comparison of Treatment Resistance.Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis.Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?Antidepressant-induced activation in children and adolescents: Risk, recognition and management.Effect of Abrupt Discontinuation of Antidepressants in Critically Ill Hospitalized Adults.Prescribing of psychiatric medication to bereaved parents following perinatal/neonatal death: an observational study.The importance of long-term tolerability in achieving recovery.Paroxetine controlled-release formulation in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled study in Japan and Korea
P2860
Q24610225-9BA15E4C-6EC5-4D1C-8AFA-3831B1B6ED29Q24625025-2E14731E-7692-4F51-8665-657BC08516E9Q28202313-86BBA400-8E58-41EC-8428-2F6822BBDE74Q28539086-AA1E6CC4-DFB1-4584-814E-D492BDBA7D69Q30449347-A2A2855F-8C03-4220-8F5E-F29FB984D9CEQ31121202-46C7B142-89A9-448A-8529-8CFCFE709A50Q34028944-53E841B9-3D1A-4DEC-8B15-E9A7DA8C50E3Q34162104-0A64491E-8EB0-45B9-9B9E-37CB00069291Q34433880-ACAB75F3-2E51-46F5-86B6-AE61FE2EE124Q34974832-8C4D2623-EDDF-4819-A505-1F113ECD3EA0Q35236337-AF883D11-363F-4AB8-86A3-E0B33811D65AQ35236630-1D61E4DF-9006-4D2B-9D7B-E7C62552B7A9Q35560309-7DEA3903-EC12-4874-B6CA-42C35F44B482Q35678803-8FF3C754-F607-408A-AE48-CA8458115B07Q35691907-35419282-B814-4430-ABB2-58DB46D0DCC0Q35873740-FA935ED4-984D-425B-8143-002B08447B02Q35919158-92CE0140-7F10-4586-908A-3A24CC28AEACQ35977716-A9D1BE78-66C7-4B67-AF16-24127266443EQ36103341-27911008-3D15-448B-835E-CA41604F44EBQ36106955-83C1BD6B-C691-4A04-91C6-FFAD91FDEF8DQ36107118-A050D7BF-134A-4844-A484-C9D8790F1DD4Q36771550-8211B8A7-DA9E-4E08-85B0-90800DBAEA7EQ37160021-81A38712-BE58-47B4-B4FC-31395D88D3D0Q37656475-5FD3B2F0-4AD2-4E34-9D27-6E29B5E3B19BQ37939221-72275992-B87E-42FE-921F-641494083B06Q38089040-9615BEC4-995B-4D76-AACC-7163897F61BEQ38238790-2F0A37BA-D55D-4233-8B83-48E25E0926B2Q38831882-4C65A61C-AC37-4278-B5C2-F33D00D1D87AQ38969500-27411BAD-C814-43CC-B88B-237A428FC202Q41025993-D9CE2644-88E4-4C68-AF39-0B7258F85BADQ43045040-35DBBC21-DE1A-4D7F-A424-C31066D5779CQ46430554-88936311-C724-49A2-859E-3FE03645BB91Q46599065-92EDB722-4D2F-46CC-8C43-CD0A89320C94Q46705998-3C83F7B8-5995-412E-959F-1E37254A33B0Q47642434-75DDE205-B20D-4575-AC1C-E9C1265CB4D9Q47690776-05762C97-F4FC-4365-8452-396150A2E54CQ47822959-D3F55C8D-86FB-4944-98AD-5356A65F6932Q48518933-A20382A3-86A5-41B1-AE6E-BC95081757CAQ57226138-EA9FEC24-0636-415B-A8D6-DF1E915BF6B5
P2860
description
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Jahr 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2001)
@en
vedecký článok (publikovaný 2001)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd in 2001)
@nl
наукова стаття, опублікована у 2001
@uk
مقالة علمية (نشرت عام 2001)
@ar
name
Antidepressant discontinuation syndromes
@ast
Antidepressant discontinuation syndromes
@en
Antidepressant discontinuation syndromes
@nl
type
label
Antidepressant discontinuation syndromes
@ast
Antidepressant discontinuation syndromes
@en
Antidepressant discontinuation syndromes
@nl
prefLabel
Antidepressant discontinuation syndromes
@ast
Antidepressant discontinuation syndromes
@en
Antidepressant discontinuation syndromes
@nl
P1433
P1476
Antidepressant discontinuation syndromes
@en
P2093
P M Haddad
P304
P356
10.2165/00002018-200124030-00003
P407
P577
2001-01-01T00:00:00Z
P6179
1009945036